SCHEMBL14907987

SCHEMBL14907987

CC(C)(C)OC(=O)NCC(=O)Nc1ccccc1CNC(=S)NCc1ccnc2[nH]ccc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.37
TSHR P16473 2/20 0.37
JAK1 P23458 6/20 0.35
JAK2 O60674 5/20 0.35
JAK3 P52333 3/20 0.35
TYK2 P29597 2/20 0.35
ACACB O00763 1/20 0.35
AURKB Q96GD4 2/20 0.34
EGFR P00533 1/20 0.34
RAF1 P04049 1/20 0.34
KDR P35968 1/20 0.34
MAP2K2 P36507 1/20 0.34
MAP2K1 Q02750 1/20 0.34
NUDT1 P36639 1/20 0.34
KLKB1 P03952 1/20 0.34
CTSL P07711 2/20 0.33
MAPKAPK2 P49137 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ROCK1 Q13464 1/20 0.33
NAMPT P43490 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14907981 0.85 AURKB (0.43) JAK1JAK2AURKBEGFRRAF1
SCHEMBL14907667 0.84 NUDT1 (0.39) ALDH1A1JAK1JAK2TYK2NUDT1
SCHEMBL14907957 0.84 NUDT1 (0.39) ALDH1A1TSHRJAK1JAK2TYK2
SCHEMBL14894074 0.83 TSHR (0.41) ALDH1A1TSHRJAK1JAK2TYK2
SCHEMBL14907649 0.83 JAK1 (0.42) JAK1JAK2JAK3TYK2ACACB
SCHEMBL14894091 0.83 CIT (0.38) ALDH1A1JAK1JAK2JAK3TYK2
SCHEMBL14894279 0.82 NUDT1 (0.38) ALDH1A1JAK1JAK2TYK2NUDT1
SCHEMBL14894259 0.82 BTK (0.40) ALDH1A1JAK1JAK2JAK3TYK2
SCHEMBL14907815 0.82 SMN1; SMN2 (0.43) ALDH1A1JAK1JAK2TYK2NUDT1
SCHEMBL14907664 0.81 JAK2 (0.41) JAK1JAK2JAK3TYK2NUDT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9174984-B2 Chemical compounds GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2015-11-03 US disclosed
US-20140296204-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2014-10-02 US disclosed
WO-2013062945-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2013-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140296204-A1 CHEMICAL COMPOUNDS DNMT1, DNMT3A, DNMT3B ALDH1A1 1016/4885TSHR 4618/4885JAK1 1077/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.